Diabetes a obezita - Issue 41/2021
7
The potential of induced pluripotent stem cells in the study and treatment of monogenic diabetes
Terézia Valkovičová, Martina Škopková, Ying Cai, Juraj Staník, Miriam Cnop, Daniela Gašperíková
16
Discordance between blood glucose and HbA1c – is an explanation possible according to the biokinetic model of glycation?
Oliver Rácz, Peter Dombrovský, Vladimír Heriban, Marek Brenišin, Katarína Muriová
23
29
Specifics of choosing antidiabetic treatment for elderly patients with type 2 diabetes mellitus
Zbynek Schroner, Vladimír Uličiansky
35
39
What helps us in deciding on antidiabetic treatment for individual patients – case reports from routine clinical practice
Zuzana Ondreičková, Martina Gubíková, Zbynek Schroner
44
Familial chylomicronemia – pathogenesis, clinical manifestations and a case report
Katarína Rašlová, Alexander Klabník, Miroslava Hučková, Daniela Gašperíková, Anna Maňková, Michal Vrablík, Richard Češka, Daniela Balažiová
60
Education of diabetic patients during the COVID-19 pandemic
Andrea Bukovská
Diabetes a obezita
2021 Issue 41
Most read in this issue
- Discordance between blood glucose and HbA1c – is an explanation possible according to the biokinetic model of glycation?
- Today we can influence overweight and obesity – and thus prevent their consequences, as is the development of diabetes or cardiovascular disease
- The potential of induced pluripotent stem cells in the study and treatment of monogenic diabetes
- News in the field of 2nd generation of basal insulin analogs in type 1 diabetes and data from continuous glucose monitoring